White House says DOJ will defend government's authority to promote vaccine requirement

Published 12/01/2021, 08:45 AM
Updated 12/01/2021, 10:02 AM
© Reuters. FILE PHOTO: Syringes with a dose of the coronavirus disease (COVID-19) vaccine are ready for injections at a vaccine clinic at La Colaborativa in Chelsea, Massachusetts, U.S., November 30, 2021.   REUTERS/Brian Snyder

By Nandita Bose

WASHINGTON (Reuters) -The White House said on Wednesday the U.S. Department of Justice "will vigorously defend" the government's authority to promote its vaccine requirement in federal contracting after courts blocked the Biden administration from enforcing two vaccine mandates.

A U.S. District Judge in Louisiana on Tuesday temporarily blocked the Centers for Medicare & Medicaid Services (CMS) from enforcing its vaccine mandate for healthcare workers.

A U.S. District Judge in Kentucky blocked the administration from enforcing a regulation that new government contracts must include clauses requiring that contractors' employees get vaccinated.

The legal setbacks, spurred by Republican state attorneys general, conservative groups and trade organizations that have sued to stop the regulations, added to a string of court losses for the Biden administration over its COVID-19 policies.

They also come amid concerns that the Omicron coronavirus variant could trigger a new wave of infections and curtail travel and economic activity around the world.

The administration's most sweeping regulation - a workplace vaccine-or-testing mandate for businesses with at least 100 employees - was temporarily blocked by a federal appeals court in early November.

"We know vaccine requirements work...We are confident in the government's authority to promote economy and efficiency in federal contracting through its vaccine requirement and the Department of Justice will vigorously defend it in court," a White House spokesperson told Reuters on Wednesday.

On Wednesday, the Biden administration said a total of 92% of U.S. federal workers have received at least one dose of a COVID-19 vaccine.

© Reuters. FILE PHOTO: Syringes with a dose of the coronavirus disease (COVID-19) vaccine are ready for injections at a vaccine clinic at La Colaborativa in Chelsea, Massachusetts, U.S., November 30, 2021.   REUTERS/Brian Snyder

President Joe Biden unveiled regulations in September to increase the U.S. adult vaccination rate beyond the current 71% as a way of fighting the pandemic, which has killed more than 750,000 Americans and has weighed on the economy.

Earlier this week, the White House told federal agencies they could delay punishing thousands of federal workers who failed to comply with a Nov. 22 COVID-19 vaccination deadline.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.